Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent

Bogdan Barz1, Brigita Urbanc

  • 1Physics Department, Drexel University, Philadelphia, Pennsylvania, United States of America.

Plos One
|April 18, 2012
PubMed

Insights

Alzheimer's disease research reveals distinct molecular behaviors between Amyloid β-protein (Aβ) alloforms Aβ(1-40) and Aβ(1-42). These differences in dimer flexibility and charged amino acid interactions may explain varying Aβ oligomer toxicity.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Neuroscience

Background:

  • Amyloid β-protein (Aβ) aggregation is central to Alzheimer's disease (AD) pathology.
  • The two main alloforms, Aβ(1-40) and Aβ(1-42), exhibit distinct assembly and toxicity due to a 5% structural difference.

Purpose of the Study:

  • To investigate the molecular dynamics and conformational differences between Aβ(1-40) and Aβ(1-42) dimers.
  • To explore the role of charged amino acids in Aβ alloform assembly and potential toxicity.

Main Methods:

  • Utilized Discrete Molecular Dynamics (DMD) for initial studies.
  • Employed fully atomistic Molecular Dynamics (MD) simulations with OPLS-AA force field and SPCE/TIP3P water models.
  • Analyzed free energy landscapes, conformational variability, and salt bridge formation.

Main Results:

  • Atomistic simulations showed larger, less compact conformations than DMD predictions.
  • Aβ(1-42) dimers exhibited greater conformational variability and N-terminal flexibility than Aβ(1-40) dimers.
  • Salt bridge formation increased with dimerization, with notable differences in K28 propensity between alloforms.

Conclusions:

  • Aβ(1-42) dimers display increased flexibility and solvent exposure of charged residues compared to Aβ(1-40).
  • Specific charged amino acid interactions (e.g., R5, K28) differ between alloforms and may influence oligomer toxicity.
  • Findings provide molecular insights into alloform-specific Aβ assembly relevant to Alzheimer's disease pathogenesis.